Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2013 - 2026)

Ionis Pharmaceuticals' Other Working Capital Changes history runs 14 years deep, the most recent figure standing at $7.4 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 153.87% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at -$48.6 million (down 182.47% YoY), while the FY2025 annual figure was -$69.7 million, down 369.68% from the prior year.
• Other Working Capital Changes was $7.4 million for Q1 2026 at Ionis Pharmaceuticals, up from -$19.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $56.2 million in Q2 2024 to a low of -$61.8 million in Q4 2023.
• Historically, Other Working Capital Changes has averaged $277529.4 across 5 years, with a median of -$1.2 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes jumped 5806.74% in 2023, then tumbled 1214.27% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $26.2 million in 2022, then sank by 335.39% to -$61.8 million in 2023, then surged by 128.65% to $17.7 million in 2024, then plunged by 208.07% to -$19.1 million in 2025, then surged by 138.63% to $7.4 million in 2026.
• The last three Other Working Capital Changes figures came in at $7.4 million (Q1 2026), -$19.1 million (Q4 2025), and -$16.1 million (Q3 2025), per Business Quant data.